CD276 and glioblastoma: This study aimed to explore the prognostic impact of co-expression of B7-H3 and PD-L1 in tumor tissue on clinical outcomes, treatment efficacy, and OS in grade 4 IDH wt glioblastoma, a subgroup characterized by high recurrence rates and poor response to treatment.